Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
Graça M. Dores(United States Food and Drug Administration), Lois B. Travis(Indiana University – Purdue University Indianapolis), Rochelle E. Curtis(National Institutes of Health), Hans H. Storm(Danish Cancer Society), Bengt Glimelius(Uppsala University), Catherine Metayer(Ontario Institute for Cancer Research), Mary Gospodarowicz(University Health Network), Eero Pukkala(Tampere University), Eric J. Holowaty(Cancer Care Ontario), Marilyn Stovall(The University of Texas MD Anderson Cancer Center), Charles F. Lynch(University of Iowa), Timo Joensuu(University of Helsinki), Michael Andersson(University of Copenhagen), E. Aileen Clarke(Ontario Institute for Cancer Research), Tom Wiklund(Lund University), Mars B. vanʼt Veer(Erasmus University Rotterdam), Flora E. van Leeuwen(The Netherlands Cancer Institute)
Cited by 564
Related Papers
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
|New England Journal of Medicine|2000|4.1k
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
|The Lancet|2008|1.9k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
|JNCI Journal of the National Cancer Institute|2005|830